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Aspergillus nidulans utilizes phenylacetate as a car-
bon source via homogentisate, which is degraded to fu-
marate and acetoacetate. Mutational evidence strongly
suggested that phenylacetate is converted to homogen-
tisate through two sequential hydroxylating reactions
in positions 2 and 5 of the aromatic ring. Using cDNA
substraction techniques, we have characterized a gene,
denoted phacA, whose transcription is strongly induced
by phenylacetate and which putatively encodes a cyto-
chrome P450 protein. A disrupted phacA strain does not
grow on phenylacetate but grows on 2-hydroxy- or 2,5-
dihydroxyphenylacetate. Microsomal extracts of the dis-
rupted strain are deficient in the NADPH-dependent
conversion of phenylacetate to 2-hydroxyphenylacetate.
We conclude that PhacA catalyzes the ortho-hydroxyla-
tion of phenylacetate, the first step of A. nidulans phe-
nylacetate catabolism. The involvement of a P450 en-
zyme in the ortho-hydroxylation of a monoaromatic
compound has no precedent. In addition, PhacA shows
substantial sequence divergence with known cyto-
chromes P450 and defines a new family of these en-
zymes, suggesting that saprophytic fungi may represent
a source of novel cytochromes P450.
Phenylacetate is a precursor for benzylpenicillin pro-
duction. phacA disruption increases penicillin produc-
tion 3–5-fold, indicating that catabolism competes with
antibiotic biosynthesis for phenylacetate and strongly
suggesting strategies for Penicillium chrysogenum
strain improvement by reverse genetics.
Aerobic degradation of aromatic hydrocarbons by microbes
involves the action of oxygenases (enzymes that incorporate
one or two atoms from dioxygen into substrates) acting at two
different levels in specific catabolic pathways (1, 2). First, ox-
ygenase enzymes acting at the upstream segment of these
pathways incorporate one (monooxygenases, aromatic ring hy-
droxylases) or two (aromatic ring dioxygenases) oxygen atoms
into the aromatic substrate as hydroxyl groups, preparing the
ring for a subsequent ring-opening step. In this second step, the
dihydroxylated aromatic ring is opened by ring-cleavage
dioxygenases.
Monooxygenases are a mechanistically diverse group of en-
zymes (1) including, for example, flavoproteins such as p-hy-
droxybenzoate hydroxylase (3), multicomponent enzymes such
as Pseudomonas mendocina toluene 4-monoxygenase, in which
one of the terminal hydroxylase polypeptides contains a binu-
clear iron cluster (4), or heme-containing cytochrome P450
systems. Monooxygenases of the cytochrome P450 superfamily
(5, 6) are widely distributed among living organisms and cat-
alyze a multiplicity of biosynthetic and catabolic reactions,
usually with narrow substrate specificity, including the hy-
droxylation of a variety of lipophylic drugs.
In common with other saprophytic microbes, the genetically
amenable, obligate aerobic fungus Aspergillus nidulans shows
notable metabolic versatility. For example, it can use the aro-
matic hydrocarbon compound phenylacetate (PhAc)1 as sole
carbon source. Despite the abundant information available on
the catabolic pathways of other aromatic compounds, which
have been extensively studied in bacteria, our understanding of
PhAc degradation pathways is scarce. In Pseudomonas putida
U, it is known that PhAc is degraded through phenylacetyl-CoA
(7), although the ring cleavage steps remain uncharacterized.
In A. nidulans, PhAc degradation proceeds through 2,5-dihy-
droxy-PhAc (homogentisate, see Fig. 1). The three structural
genes mediating the conversion of homogentisate to Krebs cycle
intermediates (i.e. the “lower” PhAc pathway) have been char-
acterized (8–10,) but the steps leading to homogentisate have
not yet been reported. We describe here mutational and molec-
ular analysis showing that A. nidulans PhAc catabolism pro-
ceeds via homogentisate through two sequential hydroxylating
steps, of which the first is the 2-hydroxylation of the ring
catalyzed by a novel cytochrome P450. Targeted inactivation of
this gene results in penicillin overproduction.
EXPERIMENTAL PROCEDURES
Fungal Strains, Media, and Growth Conditions—A nidulans strains
carried markers in standard use (11). Standard media for A. nidulans
(12) were used for strain maintenance, growth tests, and transforma-
tion. Complementation tests were carried out in constructed diploids.
A biA1 strain was the source of cDNA, and a biA1 methG1 argB2
strain was the recipient strain for phacA gene disruption. A biA1
methG1 strain was used as wild type control in experiments with the
disrupted strains. Culture conditions inducing high levels of expression
of the PhAc catabolic genes have been described (13) and were used to
grow mycelia for protein extraction. PhAc and its monohydroxy and
dihydroxy derivatives were used as sole carbon source at 10 mM (al-
though homogentisate was occasionally used at 25–50 mM), and 10 mM
ammonium chloride was used as sole nitrogen source.
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Isolation of PhAc Nonutilizing Mutants—2-, 3-, and 4-fluorophenyl-
acetate at a 5 mM concentration were shown to prevent growth of A.
nidulans in the presence of a derepressing carbon source, indicating
that their catabolism was toxic for the mold. However, some residual
growth was observed when plates were incubated for more than 3 days
at 37 °C. Sectors of markedly more vigorous mycelia frequently arose
after prolonged incubation. Although the reason why catabolism of
these PhAc derivatives results in toxicity is not clear, preliminary tests
showed that mutations preventing the toxicity of 2- and 3-fluorophen-
ylacetate also prevented the catabolism of PhAc. Therefore, conidio-
spores of a yA2 pantoB100 strain were plated to obtain isolated colonies,
which were transferred to minimal medium with 0.05% lactose (w/v) as
carbon source in the presence of 5 mM 2- or 3-fluorophenylacetate.
Sectors with more vigorous growth were purified and tested for the
utilization of different PhAc derivatives as sole carbon source. Two
major classes were found, which were denoted class I and II (see
“Results”).
phacA Gene Disruption—A pUC18-based plasmid denoted
pPhacA::argB was constructed by standard techniques. This plasmid
contains (starting from the lacZ promoter in pUC18) 0.94 kbp of the
phacA upstream region sequentially followed by its genomic coding
region up to codon 297, a genomic, 3.2-kbp fragment containing an
argB1 allele, the genomic sequence of phacA corresponding to codons
393–518, and finally 1.2 kbp of the phacA 39-downstream region. This
insert was purified from the plasmid after digestion with EcoRI and
used for transformation (14). Transformed (arginine-independent)
clones in which the resident phacA gene had been replaced by the
transforming fragment were identified by Southern analysis. The mu-
tated allele would encode a protein truncated at residue 297 and there-
fore would lack the predicted region involved in heme binding.
Characterization of phacA cDNA and Genomic Clones—phacA cDNA
clones were obtained by differential screening of a cDNA library en-
riched in PhAc-induced transcripts, as described (8–10). Seven cDNA
clones were obtained. The insert of one such clone was used to isolate
genomic clones from a standard lEMBL4 library. Cross-hybridizing
sequences were mapped to two contiguous BamHI fragments, 2.4 kb
and 1.9 kb long (a BamHI site was shown to split the phacA open
reading frame). Nucleotide sequencing and comparison of genomic and
cDNA clones revealed the intron-exon organization of the gene and
showed that all seven cDNA clones were incomplete at the N-terminal
coding region, the longest of which (at the 59-end) ended within pre-
dicted codon 6. cDNAs including the predicted initiation codon were
obtained by direct polymerase chain reaction amplification of the cDNA
library using an internal phacA primer and lgt10-specific primers
followed by a second polymerase chain reaction reaction primed with
the above internal oligonucleotide and a second oligonucleotide ending
1 nucleotide upstream of the ATG codon. The presence of the ATG codon
in the resulting cDNA product (and the absence of introns between
codons 1 and 6) was confirmed by sequencing.
Preparation of Microsomes and Enzyme Assays—Mycelia from the
isogenic DphacA and phacA strains were pregrown in glucose minimal
medium, washed, transferred to 10 mM PhAc minimal medium, and
incubated for an additional 4 h at 37 °C to induce transcription of genes
for PhAc catabolism (13). Cells were collected by filtration, washed,
resuspended in 100 mM potassium phosphate buffer, pH 7.0, and dis-
rupted with a glass bead beater (Braun, 0.5-mm glass beads) at 4 °C.
Crude extracts were clarified after centrifugation at 22,000 3 g for 15
min. Microsomal pellets were recovered after centrifugation at
100,000 3 g for 1 h and resuspended in 100 mM potassium phosphate
buffer, pH 7.0. These extracts contained 1–4 mg/ml protein. Enzyme
activities of the microsomal extract were determined using standard
procedures (15, 16) with minor modifications. NADPH-cytochrome
P450 reductase was assayed in 1-ml reactions at 25 °C with 0.1 M
phosphate buffer, pH 7.0, following the NADPH-dependent reduction of
cytochrome c (0.05 mM initial concentration; e550 5 21 mM21 cm21) or
ferrycyanide (0.5 mM initial concentration; e420 5 1.02) by the decrease
of absorbance at 550 nm and 420 nm, respectively.
PhAc 2-hydroxylase was assayed by measuring the formation of
2-hydroxy-PhAc in a reaction that required PhAc (added at 1 mM) and
NADPH (also at 1 mM) in the presence of a microsomal fraction. 2-Hy-
droxy-PhAc was chemically determined using diazotized 4-nitroaniline
essentially as described (17). Absorbance was read at 550 nm and
converted to nmol of 2-hydroxy-PhAc using a reference plot. The range
of linear response was 1–100 nmol of 2-hydroxy-PhAc. This method also
detected 3-hydroxy-PhAc, and therefore, the identity of the reaction
product as 2-hydroxy-PhAc was confirmed by direct HPLC analysis of
the reaction mixtures (see “Results”). Proteins were precipitated in the
presence of 5% (w/v) trichloroacetic acid, and 10 ml samples were in-
jected into a Nucleosil 300–5 C18 column (250 3 4 mm) coupled to a
11 3 4-mm precursor column of this support, using as mobile phase (at
0.6 ml/min) a solution containing 50 mM monohydrogen potassium
phosphate, 0.1 mM EDTA, 100 mM trifluoroacetic acid, and 8% (v/v)
acetonitrile. Detection was at 220 nm.
Penicillin Production—Cultures for penicillin production were inoc-
ulated with spores of the DphacA or the phacA1 strain in penicillin
production broth (18) with 2% lactose as the main carbon source, 2.5%
(w/v) corn steep liquor, and the indicated concentrations of sodium
phenylacetate. Flasks were shaken at 250 rpm at 37 °C. Samples were
taken at different time points and used to measure penicillin using a
bioassay with Micrococcus luteus, with penicillin G as standard (18).
RESULTS
The “Upper” Phenylacetate Degradation Pathway—We found
that 2-, 3-, or 4-fluoro-PhAc prevents A. nidulans growth on
0.05% (w/v) lactose as carbon source. We therefore selected
mutations resulting in fluorophenylacetate resistance, assum-
ing that they would prevent PhAc utilization and following
Apirion (19), who used fluoroacetate resistance to select acetate
nonutilizing mutants. Mutations preventing PhAc utilization
(phac) were efficiently selected with 2-fluorophenylacetate.
They were recessive in diploids, indicating that they represent
loss-of-function mutations. They were classified in two major
classes. Class I mutants did not grow on PhAc but grew on
2-hydroxy-PhAc or 2,5-dihydroxy-PhAc. By contrast, class II
mutants did not grow on either PhAc or 2-hydroxy-PhAc but
grew on 2,5-dihydroxy-PhAc. Class I or II mutations did not
affect growth on acetate, Phe, Tyr, 3- or 4-hydroxy-PhAc, and
3,4-dihydroxy-PhAc, showing that they specifically prevented
PhAc catabolism. Mutations in class I complemented class II
mutations. As 2,5-dihydroxy-PhAc is known to be an interme-
diate of PhAc catabolism (8–10), these data are consistent with
the pathway shown in Fig. 1 in which PhAc is converted into
homogentisate through two hydroxylating reactions, prevented
by class I and class II mutations, respectively.
Molecular Cloning of phacA, a Gene Encoding a Novel Cyto-
chrome P450—We have previously used a differential screen-
ing procedure of a subtracted cDNA library to isolate cDNA
clones representing transcripts induced by PhAc (8–10). This
collection of cDNAs included clones for the three genes (fahA,
maiA, and hmgA) of the lower PhAc pathway (Fig. 1; Refs.
8–10). Among the remaining cDNA clones, those that did not
represent these previously described genes were identified and
classified by restriction enzyme mapping and/or partial cDNA
FIG. 1. The A. nidulans phenylacetate degradation pathway.
Shown are the steps required for PhAc degradation to Krebs cycle
intermediates. Enzymes in the upper pathway are specific for PhAc.
Enzymes in the lower pathway (gene names italized) are common to
PhAc and Phe/Tyr catabolism (indicated with horizontal arrows). Phe
and Tyr are also degraded through homogentisate.
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sequencing. Seven overlapping cDNAs represented a novel
PhAc-induced transcript whose gene was named phacA and
which contained an open reading frame putatively encoding a 518-
residue polypeptide (Mr 58,495). DNA sequencing of genomic clones
showed that the phacA-coding region is interrupted by three in-
trons, 65, 56, and 53 nucleotides long. The nucleotide sequence of
phacA and the amino acid sequence of its derived protein product
have been deposited in the DDBJ/EMBL/GenBank data bases un-
der accession number AJ132442. Blastp searches against nonre-
dundant Swissprot1Translation of EMBL nucleotide sequence
data bases revealed that all 20 entries showing the highest amino
acid sequence identity to PhacA were cytochrome P450 proteins of
the CYP1 family (of which 19 were CYP1A1 P450s), including
mammalian and fish proteins but only a single human CYP. Iden-
tity levels were in the 25% range, with the highest identity (27.4%
in a 465 residue overlap) shown by a Sparus aurata (gilthead sea
bream) P450 protein. Cytochromes P450 are heme-thiolate en-
zymes, and PhacA residues 431 to 439 contain the peptide motif
Gly-Xaa-Gly-Xaa-Xaa-Xaa-Cys-Xaa-Gly (where Xaa indicates any
amino acid), which is involved in heme binding in proteins of this
class (6). We conclude that phacA encodes a cytochrome P450. The
above levels of identity are below those required to place it in an
already existing family (.40% identity required (5)). Therefore,
PhacA defines a new family of these proteins.2 It has been denoted
CYP504 using the current P450 nomenclature system.
phacA Is Strongly Induced by Phenylacetate—phacA tran-
script levels were analyzed by Northern analysis in cells grown
in glucose and subsequently transferred to minimal media,
each containing a different carbon source. This analysis (Fig. 2)
showed that phacA transcription is strongly induced by PhAc
and largely repressed by glucose (PhAc plus glucose, Fig. 2).
The transcript was absent in cells transferred to glucose alone
or to gluconeogenic substrates acetate or glutamate. 2-Hy-
droxy-PhAc was also a strong inducer (although less so than
PhAc), and 3-hydroxy-PhAc was a weak inducer. 4-Hydroxy-
PhAc, 2,5-, or 3,4-dihydroxy-PhAc did not induce phacA tran-
scription. Notably, Phe (but not Tyr) induced phacA transcrip-
tion to some extent. These results support the contention that
phacA is involved in PhAc catabolism.
The Phenotype of a Disruption Strain Is Consistent with
phacA Encoding a PhAc 2-Hydroxylase—To confirm the in-
volvement of PhacA in PhAc catabolism, we constructed a
disruption-deletion phacA mutation by reverse genetics. We
transformed an argB2 arginine-requiring strain with a linear
DNA fragment carrying a mutated phacA gene in which a
3.2-kbp fragment containing an argB1 allele replaced a 289-
base pair NaeI-KpnI phacA genomic fragment including codons
298–392 (see Fig. 3). This mutant phacA gene would encode a
PhacA protein truncated at residue 297 and therefore lacking
the 221 C-terminal residues, which include the essential Cys-
containing peptide motif involved in heme binding. Homokary-
otic transformant clones were purified after repeated streaking
on medium lacking arginine and analyzed by Southern blot
hybridization. Two transformants showing an identical hybrid-
ization pattern consistent with the integration event shown in
Fig. 3 were chosen for further analyses. Both grew normally on
0.05% (w/v) lactose but, in contrast to the wild type, showed
residual growth (similar to that observed in the absence of a
carbon source) on PhAc-minimal medium (Fig. 3), showing that
PhacA is indeed involved in PhAc catabolism. By contrast, both
transformants were able to grow on 2-hydroxy-PhAc (Fig. 3).
These data indicate that PhacA is involved in the ortho-hy-
droxylation of PhAc. The disruption-deletion mutation (denot-
ed DphacA) was recessive in diploids (in agreement with its
predicted loss-of-function phenotype) and did not complement
phac-4, a prototype of classical class I mutations that, in com-
mon with DphacA, leads to inability to use PhAc but allows
growth on 2-hydroxy-PhAc. phac-4 is therefore a phacA allele
that we renamed phacA4.
DphacA Microsomes Are Deficient in P450 PhAc 2-Hydroxyl-
ating Activity—Most eukaryotic cytochromes P450 are micro-
somal enzymes. Electrons are transferred to their catalytic
heme center from (NADPH)-cytochrome P450 reductase, a mi-
crosomal enzyme containing FAD and FMN (see Fig. 4A). We
prepared microsomal fractions from wild type and DphacA cells
induced with PhAc, which showed similar (NADPH)-cyto-
chrome P450 reductase activity, as assayed by the NADPH-de-
pendent reduction of artificial electron acceptors such as ferri-
cyanide or cytochrome c (20) (Fig. 4A). The corresponding
phacA1 and DphacA soluble fractions showed similar, high
levels of homogentisate dioxygenase (a soluble enzyme of the
PhAc degradation pathway, data not shown), indicating the
equivalent induction of PhAc catabolism in both strains.
Following incubation in vitro of wild type microsomes with2 David R. Nelson, personal communication.
FIG. 2. Northern analysis of phacA transcript levels. Cells were
grown on minimal medium with 0.3% (w/v) glucose as sole carbon
source for 16 h at 37 °C and transferred to media with the indicated
carbon sources (glucose at 1% (w/v), all aromatic compounds, and glu-
tamate at 10 mM and potassium acetate at 30 mM; 2carbon indicates no
carbon source added). These secondary cultures were incubated for a
further 1 h at 37 °C. Mycelia were then harvested and used to isolate
RNA (18). The probe was a 1.2 kb phacA cDNA clone (4FG4). Actin
transcript was used as loading control.
FIG. 3. Disruption of phacA. The phacA gene was replaced by a
mutant version after transformation with a linear DNA fragment in
which phacA codons 298–392 had been replaced by a 3.2-kbp DNA
fragment containing the argB1 gene (see “Experimental Procedures”).
This mutant allele encodes a PhacA protein truncated after residue
297.Two transformants (denoted DphacA #3 and #4) carrying the ex-
pected disruption-deletion mutation were purified and tested for
growth on minimal medium with 0.05% (w/v) lactose, 10 mM PhAc, or 10
mM 2-hydroxy-PhAc as sole carbon source, as indicated. A wild type
strain and a strain carrying a null (DhmgA) mutation in the homogen-
tisate dioxygenase gene (see Fig. 1) were used as controls. Plates were
incubated for 4 days at 37 °C before being photographed.
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PhAc and NADPH, we detected the formation of a monohy-
droxylated PhAc derivative using a chemical detection method
((Fig. 4A; see “Experimental Procedures”). Direct HPLC anal-
ysis of the reaction mixture showed that this compound was
2-hydroxy-PhAc and that its formation was absolutely depend-
ent on the presence of both PhAc and NADPH (Fig. 4B). This
showed that A. nidulans microsomes contain a phenylacetate
ortho-hydroxylating activity. This activity was markedly and
reproducibly reduced but not abolished by the DphacA muta-
tion (Fig. 4, A and B). Finally, wild type mycelia pregrown in
glucose and transferred to media containing PhAc secreted
2-hydroxy-PhAc to the culture supernatant (Fig. 5). In agree-
ment with the above in vitro assays, secretion of 2-hydroxy-
PhAc was also markedly reduced, but not abolished, by the
DphacA mutation (Fig. 5). All these data, together with the
growth characteristics of the DphacA strain (see above),
strongly support the conclusion that phacA encodes a phenyl-
acetate 2-hydroxylase and that a second, minor enzyme show-
ing this activity is present in A. nidulans microsomes (see
“Discussion”).
phacA Disruption Results in Increased Penicillin Produc-
tion—Penicillin-producing filamentous fungi use PhAc (acti-
vated as a CoA thioester) as a precursor for penicillin G bio-
synthesis. PhAc is exchanged with the L-aminoadipyl moiety of
isopenicillin N to yield penicillin G in a reaction catalyzed by
acyl-CoA::isopenicillin N-acyltransferase (see Ref. 21 for re-
view). PhAc cannot be synthesized by fungi, and therefore it
has to be fed to penicillin cultures. We reasoned that the PhAc
degradation pathway would compete with the penicillin biosyn-
thetic pathway for PhAc, suggesting that interrupting the ini-
tial step of the degradation pathway may improve the incorpo-
ration of PhAc into penicillins. This prediction was confirmed
with the two above DphacA strains, which in independent
experiments reproducibly showed a marked elevation in peni-
cillin production over the wild type. Fig. 6 shows one such
FIG. 5. Reduced secretion of 2-hydroxyphenylacetate in a
DphacA strain. Culture supernatants of phacA1 (circles) and DphacA
(triangles) strains were assayed for the presence of 2-hydroxy-PhAc.
Mycelia were pregrown in glucose minimal medium and transferred to
PhAc. Samples were taken at the indicated time-points after the
transfer.
FIG. 4. phacA disruption results in a marked reduction of microsomal PhAc 2-hydroxylase activity. A, a cytochrome P450 monooxy-
genase catalyzes the incorporation of one of the atoms from dioxygen (as an hydroxyl group) into the aromatic ring of PhAc. The source of electrons
for such reaction is a NAPH-cytochrome P450 oxidoreductase, an enzyme that transfers electrons from NADPH through two flavin redox centers
(20). In vitro, the activity of the reductase can be monitored by using artificial electron acceptors such as ferricyanide and cytochrome c, as
indicated. Shown below are PhAc 2-hydroxylase and NAPH-cytochrome P450 oxidoreductase activities in the microsomal fractions of DphacA and
phacA1 mycelia. Formation of 2-hydroxy-PhAc was monitored with a chemical method (17). B, HPLC analysis of PhAc 2-hydroxylase in the above
microsomal fractions. The positions of standards were indicated by roman numbers as follows: I, 2,5-dihydroxy-PhAc; II, 3,4-dihydroxy-PhAc; III,
4-hydroxy-PhAc; IV, 3-hydroxy-PhAc; V, 2-hydroxy-PhAc; VI, PhAc. The retention time for authentic 2-hydroxy-PhAc was 11.82 min, whereas the
product formed in the complete phacA1 and DphacA reactions showed retention times of 11.81 and 11.86 min, respectively.
Novel Cytochrome P450 in Fungal Phenylacetate Catabolism14548
 at CSIC - Centro de Investigaciones Biológicas on Septem
ber 14, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
experiment, illustrating how the increase is already evident in
cultures supplemented with 0.125% (w/v) PhAc (1.8 mg/ml in
the wild type, 5.2 mg/ml in the DphacA strain). Moreover,
reduction of PhAc to 0.0625% (w/v) resulted in nearly a 40%
decrease in wild type penicillin production but had no decreas-
ing effect in mutant strain production (Fig. 6; for simplicity,
results with only one of the two disrupted strains are shown;
see the legend). Under such conditions, the DphacA mutation
resulted in a 4.9-fold increase in penicillin production.
DISCUSSION
We have analyzed the “upper pathway” of PhAc catabolism
(i.e. the conversion of PhAc to homogentisate, Fig. 1) in the
filamentous fungus A. nidulans. Mutational and molecular ev-
idence strongly indicates that this conversion proceeds via two
sequential hydroxylating steps, the first of which is a 2-hy-
droxylation of the aromatic ring catalyzed by a cytochrome
P450 monoxygenase encoded by the phacA gene. First, we have
isolated a class of mutations preventing growth on PhAc but
allowing growth on 2-hydroxy-PhAc or homogentisate as sole
carbon source. Second, we describe a gene, denoted phacA,
whose inactivation results in the same phenotype as the above
mutations. This DphacA mutation does not complement with a
prototypical classical mutation of the above class, indicating
that both affect the same gene. Third, phacA encodes a CYP
(cytochrome P450 monooxygenase). CYP enzymes are usually
involved in a variety of biosynthetic and catabolic hydroxylat-
ing reactions (5, 6), in agreement with the predicted PhacA
function. Fourth, phacA1 microsomal extracts catalyze the
PhAc- and NADPH-dependent synthesis of 2-hydroxy-PhAc. By
contrast, a mutant DphacA microsomal fraction is markedly
deficient in this reaction. An A. niger microsomal, NADPH-de-
pendent phenylacetate-2-monooxygenase activity previously
reported by others (17) is possibly encoded by a phacA homo-
logue. In agreement with our Northern analysis, such activity
was detected in phenylacetate-grown cells and absent from
glucose-grown cells (17).
The DphacA mutation constructed here is almost certainly a
null mutation, which strongly suggested that the residual PhAc
2-hydroxylase activity that we detected with DphacA microso-
mal extracts is encoded by a different gene. We have identified
the gene (denoted pshA) encoding this minor activity.3 In
agreement with our prediction, a double DphacA DpshA muta-
tion abolished microsomal PhAc 2-hydroxylation.3 A DpshA
strain grows on PhAc but does not grow on 3-hydroxy-PhAc
(which in the wild type is also catabolized through homogenti-
sate), indicating that pshA encodes a 3-hydroxy-PhAc 6-hy-
droxylase (i.e. and ortho-hydroxylase), converting 3-hydroxy-
PhAc to 2,5-dihydroxy-PhAc. This enzyme has been previously
described in the fungus Trichosporum cutaneum, which con-
verts PhAc to homogentisate through sequential hydroxylation
of positions 3 and 6 of the ring (22).
Higher eukaryotes have multiple cytochrome P450 monooxy-
genases catalyzing a variety of oxidative reactions. Such abun-
dance is not found in the microbial world. For example, only
three CYP genes are found in the genome of S. cerevisiae (23).
The marked metabolic versatility of filamentous fungi would
suggest a greater variety of CYP enzymes in their proteomes.
In addition to phacA, four stc genes of the A. nidulans sterig-
matocystin biosynthetic cluster encode CYP enzymes (24). The
closely related organism A. niger has a very specific benzoate-4
hydroxylase enzyme, encoded by the bphA gene (25). Notably,
PhacA and BphA each define a new CYP family, suggesting
that metabolically versatile saprophytic fungi may represent
an as yet unexplored source of variability for CYP enzymes
catalyzing novel metabolic reactions.
Industrial penicillin production by Penicillium chrysogenum
strains requires the addition of PhAc, which is the side-chain
precursor for the synthesis of penicillin G. Part of the added
PhAc is oxidized (26), and it is not transformed into penicillin.
Therefore, strain improvement programs using mutation and
selection techniques have been directed to prevent such oxida-
tion (27). Engineered expression in P. chrysogenum of a bacte-
rial phenylacetyl-CoA ligase leading to increased levels of phe-
nylacetyl-CoA available for penicillin biosynthesis resulted in
penicillin overproduction (28). We show here that targeted
disruption of the gene mediating the first step of A. nidulans
PhAc catabolism results in a 3- to 5-fold increase in penicillin
production and makes the recombinant strain less dependent
on the external supply of PhAc. This presumably results from
increased availability of phenylacetate for penicillin G biosyn-
thesis. A P. chrysogenum phacA homologue has been identified.
Therefore, these results pave the way for the improvement of P.
chrysogenum industrial strains using a similar methodology.
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